资讯

Targeted Oncology1 天
FDA Clears Phase 1 Study of TGW101 for Advanced Solid Tumor Treatment
Phase 1 trial of TGW101 in advanced solid tumors is enrolling to assess safety and pharmacokinetics and define the maximum ...
Pharmabiz3 天
US FDA clears Tagworks Pharma’s IND application and initiates phase 1 trial of TGW101 in ...
Nijmegen, Netherlands Wednesday, April 23, 2025, 13:00 Hrs [IST] ...
Cancer Research6 天
Abstract 3486: Click-to-release for controlled immune cell activation: tumor-targeted ...
Search for other works by this author on: ...
Cancer Research6 天
Abstract 1126: CLSP-1025, a first-in-class precision T cell engager for the treatment of ...
Cancer Res (2025) 85 (8_Supplement_1): 1126.